James Robinson - Creative Edge CEO and President and Director
CEO
James L. Robinson is President, Chief Executive Officer, Director of Company since 2014.
| Tenure | 10 years |
| Address | 29235 Stephenson Highway, Madison Heights, MI, United States, 48071 |
| Phone | 313-655-1669 |
| Web | https://www.cenergynutrition.com |
James Robinson Latest Insider Activity
Tracking and analyzing the buying and selling activities of James Robinson against Creative Edge stock is an integral part of due diligence when investing in Creative Edge. James Robinson insider activity provides valuable insight into whether Creative Edge is net buyers or sellers over its current business cycle. Note, Creative Edge insiders must abide by specific rules, including filing SEC forms every time they buy or sell Creative Edge'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
James Robinson over three months ago Acquisition by James Robinson of 12821 shares of Empire State subject to Rule 16b-3 | ||
James Robinson over six months ago Acquisition by James Robinson of 16156 shares of Empire State subject to Rule 16b-3 | ||
James Robinson over six months ago Purchase by James Robinson of 40000 shares of Nymox Pharmaceutical | ||
James Robinson over six months ago Purchase by James Robinson of 40000 shares of Nymox Pharmaceutical |
Creative Edge Management Efficiency
The company has return on total asset (ROA) of (0.5141) % which means that it has lost $0.5141 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.571) %, meaning that it created substantial loss on money invested by shareholders. Creative Edge's management efficiency ratios could be used to measure how well Creative Edge manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Creative Edge's Return On Capital Employed is fairly stable compared to the past year. Return On Equity is likely to rise to 3.57 in 2024, despite the fact that Return On Tangible Assets are likely to grow to (1.26). At this time, Creative Edge's Total Assets are fairly stable compared to the past year. Total Current Assets is likely to rise to about 345.2 K in 2024, despite the fact that Net Tangible Assets are likely to grow to (10.2 M).Similar Executives
| Found 7 records | CEO Age | ||
| Michael Taylor | Deciphera Pharmaceuticals LLC | 63 | |
| Scott Tarriff | Eagle Pharmaceuticals | 64 | |
| Steven Hoerter | Deciphera Pharmaceuticals LLC | 53 | |
| Peter Hecht | Ironwood Pharmaceuticals | 53 | |
| Mark Mallon | Ironwood Pharmaceuticals | 55 | |
| Eddie Gray | Dynavax Technologies | 59 | |
| Kevin Gorman | Neurocrine Biosciences | 66 | |
Management Performance
| Return On Equity | -1.57 | ||||
| Return On Asset | -0.51 |
Creative Edge Nutrit Leadership Team
Elected by the shareholders, the Creative Edge's board of directors comprises two types of representatives: Creative Edge inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Creative. The board's role is to monitor Creative Edge's management team and ensure that shareholders' interests are well served. Creative Edge's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Creative Edge's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Reid Stone, Executive VP, Secretary, Treasurer and Director | ||
| Michael Thomas, VP | ||
| Paul Thomas, Co-Founder and Sr. VP | ||
| James Robinson, CEO and President and Director | ||
| Bill Chaaban, Director | ||
| David Felten, Chief Director | ||
| Joel Stohlman, Consultant Advisor | ||
| Dr MSM, Chief Research | ||
| Sam Alawieh, Chairman Officer | ||
| Keith Thomas, Chairman of the Board and Presidentident, CEO |
Creative Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Creative Edge a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.57 | ||||
| Return On Asset | -0.51 | ||||
| Profit Margin | (0.36) % | ||||
| Operating Margin | (0.35) % | ||||
| Current Valuation | 25.28 K | ||||
| Shares Outstanding | 341.1 M | ||||
| Price To Sales | 0.1 X | ||||
| Revenue | 92.28 K | ||||
| Gross Profit | 906.73 K | ||||
| EBITDA | (1.04 M) |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Creative Edge Nutrit. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Complementary Tools for Creative Stock analysis
When running Creative Edge's price analysis, check to measure Creative Edge's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Creative Edge is operating at the current time. Most of Creative Edge's value examination focuses on studying past and present price action to predict the probability of Creative Edge's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Creative Edge's price. Additionally, you may evaluate how the addition of Creative Edge to your portfolios can decrease your overall portfolio volatility.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |
Is Creative Edge's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Creative Edge. If investors know Creative will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Creative Edge listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share 0.008 | Return On Assets (0.51) | Return On Equity (1.57) |
The market value of Creative Edge Nutrit is measured differently than its book value, which is the value of Creative that is recorded on the company's balance sheet. Investors also form their own opinion of Creative Edge's value that differs from its market value or its book value, called intrinsic value, which is Creative Edge's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Creative Edge's market value can be influenced by many factors that don't directly affect Creative Edge's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Creative Edge's value and its price as these two are different measures arrived at by different means. Investors typically determine if Creative Edge is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Creative Edge's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.